A Parallel Phase I/II Study of Low Dose Decitabine (5-Aza-Deoxycytidine) With Peginterferon Alfa-2b in Advanced Melanoma

Trial Profile

A Parallel Phase I/II Study of Low Dose Decitabine (5-Aza-Deoxycytidine) With Peginterferon Alfa-2b in Advanced Melanoma

Completed
Phase of Trial: Phase I/II

Latest Information Update: 20 Nov 2015

At a glance

  • Drugs Decitabine (Primary) ; Peginterferon alfa-2b (Primary)
  • Indications Malignant melanoma
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 19 May 2015 Planned primary completion date changed from 1 Sep 2016 to 1 May 2015 as per ClinicalTrials.gov record.
    • 19 May 2015 Planned primary completion date changed from 1 Sep 2016 to 1 May 2015 as per ClinicalTrials.gov record.
    • 19 May 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record..
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top